Treximet in the Treatment of Chronic Migraine

• Status: Completed
• Trial end date: 2012-07-01

Summary

This study is being conducted to evaluate the hypothesis that use of Treximet in patients with chronic migraine, when used on a short term daily basis and as rescue for break through attacks, will reduce migraine frequency and impact.

• Phase: Phase 4

Details

• Lead Sponsor: Cady, Roger, M.D.
• Collaborator: GlaxoSmithKline
• Treatments: Naproxen; Sumatriptan